Delta’s connection with St Vincent’s Hospital Sydney began more than 22 years ago, following her treatment for Hodgkin’s Lymphoma. Since that time, she has maintained a deep and enduring commitment to the hospital and its patients.
In 2009, Delta was appointed Patron of The Kinghorn Cancer Centre, a role she proudly continues today. In 2015, she accepted the role of Campaign Ambassador to support the building of a new state of the art Haematology, Blood and Marrow Transplant Ward at St Vincent’s Hospital in Sydney. This leading facility supports patients with haematological cancers and severe autoimmune diseases, delivering world class treatment while preserving privacy and dignity during some of the most challenging moments of care. As Campaign Ambassador, Delta played a pivotal role in helping to raise $7.3 million in private philanthropic funding required to establish the new ward.
Building on her dedicated legacy, Delta also serves as Ambassador for the St Vincent’s Cell Therapy Program, which is focused on advancing innovative stem cell and cellular therapies for the treatment of blood cancers and autoimmune diseases.
What is Cellular Therapies?
Cellular (Cell) therapies use a patient’s own cells as treatment and have the potential to transform bone marrow transplantation. These therapies offer powerful new options to treat blood cancers and other serious diseases, while also helping to fight infection and strengthen immunity.
St Vincent’s has been at the forefront of cellular therapy development, achieving strong outcomes through the use of autologous haematopoietic stem cell transplantation in the treatment of leukaemia, lymphoma and severe autoimmune diseases.
By bringing together laboratory research, patient trials and international collaborations, St Vincent’s aims to rapidly advance innovative therapies that reduce suffering and improve outcomes for people worldwide living with malignant and autoimmune disease.
The Delta Goodrem Foundation and Bourne Foundation Fellowship in Cellular Therapies
The Delta Goodrem Foundation Fellowship in Cellular Therapies was established in 2020 in partnership with St Vincent’s Hospital Sydney to support the next generation of clinician researchers in haematology. The Fellowship enables an emerging doctor researcher to explore the role of cellular therapies in the treatment of malignant and autoimmune diseases, with a particular focus on lymphoma.
Since the appointment of the first Fellow in 2021, the program has now supported five outstanding clinicians on their pathway to leadership in haematology and cancer care.
Based at The Kinghorn Cancer Centre in Sydney, the Fellowship supports a medical doctor, typically a fourth year registrar, who works concurrently as a clinician and researcher. This integrated role allows research findings to be translated directly into patient care, aligning scientific discovery with real world clinical need.
The Fellowship builds on St Vincent’s long-standing legacy by accelerating the application of research into clinical practice, improving outcomes for patients across Australia.
In January 2024, The Bourne Foundation committed to partnering with the Delta Goodrem Foundation to support the Fellowship for a further three years. In recognition of this partnership, the program was renamed the Delta Goodrem Foundation and Bourne Foundation Fellowship in Cellular Therapies.
If you would like to know more about Cellular Therapies and how you can support cancer research and innovative treatments please get in touch by emailing contact@deltagoodremfoundation.org . You can help us today by making a donation below and join with us in building a world free of cancer and life-challenging diseases.